Effexor XR Related Published Studies
Well-designed clinical trials related to Effexor XR (Venlafaxine)
Sexual function in women on estradiol or venlafaxine for hot flushes: a
randomized controlled trial. [2014]
Evaluation of the efficacy and safety of pregabalin, venlafaxine, and
carbamazepine in patients with painful diabetic peripheral neuropathy. A
randomized, double-blind trial. [2014]
Specificity profile of venlafaxine and sertraline in major depression:
metaregression of double-blind, randomized clinical trials. [2014]
Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin
receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in
generalized anxiety disorder. [2013]
Catechol-O-methyltransferase genotype as modifier of superior responses to
venlafaxine treatment in major depressive disorder. [2013]
Benefits from antidepressants: synthesis of 6-week patient-level outcomes from
double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. [2012]
Efficacy and tolerability of venlafaxine versus specific serotonin reuptake
inhibitors in treatment of major depressive disorder: a meta-analysis of
published studies. [2012]
Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. [2011.10.10]
What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies. [2011.04]
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. [2011.04]
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. [2011.03.22]
Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study. [2011]
Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in
nonresponders and responders. [2011]
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. [2010.12.10]
Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release. [2010.12]
Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states. [2010.11]
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. [2010.11]
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. [2010.11]
Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder. [2010.11]
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. [2010.09.21]
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. [2010.09]
Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet. [2010.09]
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. [2010.07]
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. [2010.06]
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment. [2010.06]
Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. [2010.05.15]
Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. [2010.03]
Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. [2010.02.01]
Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis. [2010.02.01]
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. [2010.02]
Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression. [2010]
Double-blind, placebo-controlled comparison of the antidepressant efficacy and
tolerability of bupropion XR and venlafaxine XR. [2010]
Efficacy of venlafaxine for symptomatic relief in young adult patients with
functional chest pain: a randomized, double-blind, placebo-controlled, crossover
trial. [2010]
[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study] [2009.12]
Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers. [2009.11]
Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. [2009.11]
Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial. [2009.09.30]
Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. [2009.09]
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study. [2009.07]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2009.07]
The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression. [2009.06]
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. [2009.06]
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. [2009.05]
An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder. [2009.04]
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder. [2009.04]
Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. [2009.03.17]
The efficacy of venlafaxine in the treatment of women with stress urinary incontinence. [2009.03]
Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. [2009.03]
Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia? [2009.02]
Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers. [2009.02]
Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. [2009.02]
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. [2009.01]
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. [2009.01]
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study. [2008.11]
A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo. [2008.10]
Changes in brain function during administration of venlafaxine or placebo to normal subjects. [2008.10]
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. [2008.09]
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial. [2008.09]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2008.07.17]
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. [2008.07]
The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers. [2008.07]
The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. [2008.07]
Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. [2008.07]
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. [2008.06]
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial. [2008.05.15]
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. [2008.05]
Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.04.17]
The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. [2008.04.15]
Venlafaxine for Acute Heroin Detoxification: A Double-Blind, Randomized, Control Trial. [2008.04]
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. [2008.04]
Comparison of Short-Term Venlafaxine Versus Lithium Monotherapy for Bipolar II Major Depressive Episode: A Randomized Open-Label Study. [2008.04]
An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers. [2008.03]
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. [2008.02.27]
Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine. [2008.02]
Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study. [2008.02]
Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder : A 12-Week Prospective, Open-Label, Randomized, Parallel-Group Trial. [2008]
Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. [2008]
Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects. [2008]
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases. [2007.12.15]
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial. [2007.12]
Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. [2007.11.29]
A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. [2007.11.15]
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. [2007.11]
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. [2007.10]
Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER. [2007.09]
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. [2007.08]
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. [2007.07]
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. [2007.06.23]
A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder. [2007.06.04]
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. [2007.05]
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. [2007.05]
A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. [2007.04]
Differential physiological effects of a low dose and high doses of venlafaxine in major depression. [2007.02]
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. [2007.02]
A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia. [2007]
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study. [2007]
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. [2006.11]
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. [2006.10]
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial. [2006.09.30]
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. [2006.09]
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. [2006.08]
|
